Welcome to our dedicated page for Joint news (Ticker: JYNT), a resource for investors and traders seeking the latest updates and insights on Joint stock.
The Joint Corp (NASDAQ: JYNT) operates one of the nation's largest chiropractic networks through its innovative corporate-owned and franchise clinic model. This page serves as the definitive source for investors and industry observers tracking the company's latest developments.
Access official press releases, financial updates, and operational announcements in one centralized location. Our curated collection focuses on material events including quarterly earnings reports, franchise expansion initiatives, leadership updates, and strategic partnerships that shape the company's position in the healthcare sector.
All content undergoes strict verification to ensure accuracy and relevance for stakeholders. The streamlined format enables quick scanning of key developments while maintaining depth for detailed analysis. Regular updates reflect JYNT's evolving role in making chiropractic care more accessible through its unique membership-based model.
Bookmark this page for efficient monitoring of Joint Corp's progress in transforming retail healthcare delivery. Combine these verified updates with SEC filings and market analysis for comprehensive investment research.
The Joint Corp. (JYNT) reported strong growth in Q1 2022, with revenue increasing 28% to $22.4 million and system-wide sales up 27% to $98.8 million compared to Q1 2021. Despite a net loss of $206,000, the company opened 31 clinics, achieving a total of 736 clinics, including 100 corporate clinics. Adjusted EBITDA decreased to $1.8 million from $3.5 million, influenced by rising labor costs and operational expenses. The company updated its 2022 revenue guidance to $98-102 million, affirming its target of 110-130 new franchised clinics.
The Joint Corp. (NASDAQ: JYNT), a leader in chiropractic care, will release its first quarter 2022 financial results on May 5, 2022, after market close. CEO Peter D. Holt and CFO Jake Singleton will host a conference call at 5:00 p.m. ET to discuss the results. Interested participants can listen via phone at (765) 507-2604 or (844) 464-3931 using code 5175957. A live webcast and slide presentation will be available on the company's investor relations site and can be accessed for one year. The Joint Corp. operates over 700 clinics nationwide.
The Joint Corp. (NASDAQ: JYNT) announced the acquisition of regional developer rights for Northern California for $2.4 million, effective April 1, 2022. This acquisition allows oversight of 56 franchised clinics, including 20 operational and 36 in development, plus the opportunity for 19 more clinics. CEO Peter D. Holt stated this move aims to enhance growth and margin contribution in California, signaling strategic expansion potential in the chiropractic care market.
The Joint Corp. (NASDAQ: JYNT) announced the acquisition of the regional developer territory for Northern New Jersey, encompassing four franchised clinics, for $250,000 on March 17, 2022. This strategic move aims to bolster their corporate clinic footprint in the Northeast and aligns with their goal of opening 1,000 clinics by the end of 2023. As of the announcement, they operate 99 clinics, having added three new locations since December 2021.
The Joint Corp. (NASDAQ: JYNT) announced participation in key investor events. The Maxim Group LLC 2022 Virtual Growth Conference will take place from March 28-30, featuring President and CEO Peter D. Holt and CFO Jake Singleton. The event will include a live presentation on March 28, available on demand. Additionally, Holt will participate in the SEC’s 41st Annual Small Business Forum on April 7, focusing on capital raising policy. The Joint is the largest provider of chiropractic care in the U.S., with over 700 locations and nearly 11 million patient visits annually.
The Joint Corp. (NASDAQ: JYNT), the largest provider of chiropractic care in the U.S., announced management's upcoming presentations at key conferences in March 2022. The schedule includes:
- March 10: D.A. Davidson 5th Annual Consumer Growth Conference at 1:15 PM PT / 4:15 PM ET (Virtual format).
- March 14-15: 34th Annual Roth Conference (In-person 1x1 meetings).
Presentation materials will be available on their Investor Relations website. The company continues to lead with over 700 locations and nearly 11 million patient visits annually.
The Joint Corp. (NASDAQ: JYNT) reported robust financial results for 2021, with revenue growth of 38% year-over-year, totaling $81.2 million. System-wide sales increased 39% to $361.1 million, driven by 706 clinics in operation by year-end. Quarterly results for Q4 2021 showed revenue rise to $22.4 million, a 32% increase from Q4 2020. However, net income dipped to $224,000 from $10.6 million a year prior. Looking ahead, the company anticipates 2022 revenue between $102 million and $106 million, indicating continued growth potential.
The Joint Corp. (NASDAQ: JYNT) reported significant growth in its 2021 financial results, with revenue increasing 38% to $81.2 million and system-wide sales up 39% to $361.1 million compared to 2020. The company achieved a net income of $7.2 million, though this reflects a decrease from $13.2 million in 2020. Operating income rose to $6.0 million from $5.5 million, while Adjusted EBITDA improved to $13.3 million. The company opened 130 new clinics and aims to reach 1,000 locations by the end of 2023.
On February 14, 2022, The Joint Corp. (NASDAQ: JYNT) announced the upcoming release of its fourth quarter and year-end 2021 financial results. The report will be available on February 24, 2022, after market close. Following the release, President and CEO Peter D. Holt, along with CFO Jake Singleton, will host a conference call at 5:00 p.m. ET to discuss the results. Participants can access the live call by dialing (765) 507-2604 or (844) 464-3931, using code 3285473.
For further details, visit the company's investor relations webpage.
The Joint Corp. (NASDAQ: JYNT) continues to excel in the chiropractic care market, earning accolades from top publications like Entrepreneur and Franchise Times. Recognized for outstanding growth and brand strength, The Joint ranks 57th in Entrepreneur's Franchise 500, jumps to 8th on Franchise Times' Fast & Serious list, and is acknowledged as a top multi-unit franchise. The company is targeting 1,000 operational units by 2023, emphasizing accessible and affordable chiropractic care through its innovative retail healthcare model.
FAQ
What is the current stock price of Joint (JYNT)?
What is the market cap of Joint (JYNT)?
